XML 101 R56.htm IDEA: XBRL DOCUMENT v3.25.4
EQUITY AND EARNINGS PER COMMON SHARE (Tables)
 12 Months Ended
Dec. 31, 2025
Equity [Abstract]  
Schedule Of Preferred Stock The table below presents preferred stock outstanding at SoCalGas:
PREFERRED STOCK OUTSTANDING
(Dollars in millions, except per share amounts)
 December 31,
 20252024
$25 par value, authorized 1,000,000 shares:
6% Series, 79,011 shares outstanding
$3 $3 
6% Series A, 783,032 shares outstanding
19 19 
SoCalGas - Total preferred stock22 22 
Less: 50,970 shares of the 6% Series outstanding owned by Pacific Enterprises
(2)(2)
Sempra - Total preferred stock of subsidiary$20 $20 
Schedule Of Common Stock Activity The following table provides common stock activity for the last three years.
COMMON STOCK ACTIVITY
 202520242023
Sempra:
Common shares outstanding, January 1650,629,876 631,431,732 628,669,356 
Shares issued under forward sale agreements— 17,142,858 — 
Shares issued to underwriters to cover overallotments— — 2,099,152 
RSUs vesting(1)
1,571,512 1,320,561 941,910 
Stock options exercised— 143,944 — 
Common stock investment plan(2)
1,067,446 1,151,877 1,730 
Issuance of RSUs held in our deferred compensation plans147,582 128,207 132,178 
Shares repurchased(3)
(684,748)(689,303)(412,594)
Common shares outstanding, December 31652,731,668 650,629,876 631,431,732 
(1)    Includes dividend equivalents.
(2)    Participants in the Direct Stock Purchase Plan may reinvest dividends to purchase newly issued shares.
(3)    Includes shares repurchased under repurchase programs and shares withheld from LTIP participants and individuals exercising stock options in 2024 to satisfy minimum statutory tax withholding requirements.
Schedule Of Earnings Per Share Computations
EARNINGS PER COMMON SHARE COMPUTATIONS
(Dollars in millions, except per share amounts; shares in thousands)
 Years ended December 31,
 202520242023
Sempra:
Numerator:
Earnings attributable to common shares$1,796 $2,817 $3,030 
Denominator:
Weighted-average common shares outstanding for basic EPS(1)
652,697 633,795 630,296 
Dilutive effect of common shares sold forward209 2,036 96 
Dilutive effect of stock options and RSUs(2)
920 2,112 2,341 
Weighted-average common shares outstanding for diluted EPS653,826 637,943 632,733 
EPS:
Basic$2.75 $4.44 $4.81 
Diluted$2.75 $4.42 $4.79 
(1)     Includes fully vested RSUs held in our deferred compensation plan of 500 in 2025, 617 in 2024 and 717 in 2023. These fully vested RSUs are included in weighted-average common shares outstanding for basic EPS because there are no conditions under which the corresponding shares will not be issued.
(2)    Due to market fluctuations of both Sempra common stock and the comparative indices used to determine the vesting percentage of our total shareholder return performance-based RSUs, which we discuss in Note 14, dilutive RSUs may vary widely from period-to-period.
Schedule Of Transfers (To) From Noncontrolling Interest
The following table summarizes net income attributable to Sempra and transfers (to) from CRNCI and NCI, which shows the effects of changes in Sempra’s ownership interest in its subsidiaries on Sempra’s shareholders’ equity. There were no transfers (to) from CRNCI and NCI in 2024.
NET INCOME ATTRIBUTABLE TO SEMPRA AND TRANSFERS (TO) FROM CRNCI AND NCI
(Dollars in millions)
 Years ended December 31,
 20252023
Sempra:
Net income attributable to Sempra$1,837 $3,075 
Transfers (to) from CRNCI and NCI:
Increase in shareholders’ equity from investor equity subscription 16 — 
Increase in shareholders’ equity from allocation of interests(1)
1,073 — 
Decrease in shareholders’ equity for sales of NCI— (49)
Net transfers (to) from CRNCI and NCI
1,089 (49)
Change from net income attributable to Sempra and transfers (to) from CRNCI and NCI
$2,926 $3,026 
(1)    We describe the allocation of interests in Note 12.